Amplo Biotechnology Announces Three Presentations at the European Society of Gene and Cell Therapy 31st Annual Congress

Contributed by: PR Newswire

Tags

Amplo-Biotechnology

More Like This

Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting

Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti-CD40 mAb) Phase I Trial at ESMO 2023

PR Newswire associated0

WestGene Biopharma Presents Groundbreaking mRNA Vaccine Data at ESMO 2024

WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

Merus Announces Abstract Accepted for Presentation at the ESMO Asia Congress 2024

HanchorBio to Present at the ESMO Immuno-Oncology 2023 Annual Congress